FDA’s Project Optimus aims to transform early cancer researchNovember 14, 2023PharmacyALLAMLCMLDLBCLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
NCCN guidelines highlight ‘complicated’ treatment for pediatric lymphomasJanuary 14, 2020Aggressive LymphomasPediatricsDLBCLLymphoma & Plasma Cell Disorders
Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCLDecember 9, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
CAR T-cell therapy found safe, effective for HIV-associated lymphomaSeptember 20, 2019Aggressive LymphomasLymphoma & Plasma Cell DisordersDLBCL
Bispecific CAR T-cell therapy yields complete responses in relapsed/refractory non-Hodgkin lymphomasJune 21, 2019Aggressive LymphomasLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
5F9 plus rituximab take a bite out of drug-resistant NHLJune 18, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
‘Encouraging’ responses seen with durvalumab plus R-CHOP in DLBCLJune 17, 2019Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Chemo-free Smart Start regimen looks promising in poor-prognosis DLBCLJune 7, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
SC-PEG comparable to pegaspargase in young ALL/LL patientsJune 1, 2019ALLAggressive LymphomasLeukemia, Myelodysplasia, Transplantation
Monitoring, early intervention key to CAR T safetyApril 24, 2019Aggressive LymphomasTransplantationLymphoma & Plasma Cell Disorders
Therapeutic dosing of busulfan helps reduce relapse in ASCTMarch 13, 2019TransplantationAggressive LymphomasLymphoma & Plasma Cell Disorders
Priority review granted to lenalidomide for FL, MZLMarch 2, 2019Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Barriers to CAR T use in the spotlight at first European meetingFebruary 28, 2019Aggressive LymphomasGene Therapy
Researchers characterize new subtype of high-grade DLBCLFebruary 17, 2019Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Few DLBCL patients benefit from nivolumabFebruary 14, 2019Aggressive LymphomasLymphoma & Plasma Cell Disorders
